PTC Therapeutics PTCT 深 沪
已收盘 10-09 16:00:00 美东时间
64.70
+2.140
+3.42%
华盛通- 最 高64.73
- 今 开62.52
- 成交量 117.12万股
- 最 低 62.20
- 昨 收 62.56
- 总市值 54.00亿
- 52周最高 90.87
- 市盈率 静 8.32
- 换手率 1.40%
- 52周最低 61.23
- 委 比 -80.49%
- 总股本 8346.08万
- 历史最高 90.87
- 量 比 1.07
- 振 幅 4.04%
- 历史最低 4.03
- 每 手 1
- 风险率 5.58%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多美股大行评级 | 潜在涨幅179.23%！奥本海默上调Aurora Innovation目标价至16美元，维持"跑赢大市"评级
今日重点评级关注：奥本海默：维持Aurora Innovation"跑赢大市"评级，目标价从15美元升至16美元；富国银行：维持Applied Digital"超配"评级，目标价从50美元升至55美元
10-09 16:25
RBC Capital Maintains Sector Perform on PTC Therapeutics, Lowers Price Target to $75
RBC Capital analyst Brian Abrahams maintains PTC Therapeutics (NASDAQ:PTCT) with a Sector Perform and lowers the price target from $85 to $75.
10-08 22:07
美股牛股 | Kodiak暴升178%！wAMD三期临床试验大获成功；黑莓升逾7%，Q2营收超预期，QNX业务表现强劲
Kodiak暴升178%！wAMD三期临床试验大获成功；AMC升近12%，39.7亿美元债务再融资；黑莓升逾7%，Q2营收超预期，QNX业务表现强劲>>
09-29 17:03
美股大行评级 | Muse热度发酵，Meta目标价获大幅升至875美元；闪迪获看好至2400美元，潜在升幅约27%
今日重点评级关注：Citizens：上调Quince Therapeutics评级至"跑赢大市"，目标价77美元；康托·菲茨杰拉德：维持塞德斯医疗"超配"评级，目标价从61美元升至72美元
09-23 15:30
Cantor Fitzgerald Maintains Overweight on PTC Therapeutics, Raises Price Target to $137
Cantor Fitzgerald analyst Kristen Kluska maintains PTC Therapeutics (NASDAQ:PTCT) with a Overweight and raises the price target from $130 to $137.
09-22 18:10
PTC Completes Acquisition of ST-920 Fabry Disease Gene Therapy
– Completion of BLA submission expected in Q4 2026 – WARREN, N.J., Sept. 21, 2026 /PRNewswire/ -- PTC Therapeutics, Inc., (NASDAQ: PTCT) today announced that it completed the previously anno...
09-22 04:30
PTC Therapeutics Acquires ST-920 Fabry Gene Therapy Rights
The latest update is out from PTC Therapeutics ( ($PTCT) ). On August 25, 2026,...
08-29 04:55
PTC Therapeutics To Present New Sephience Data At The 2026 Society For The Study Of Inborn Errors Of Metabolism Annual Symposium, August 25-28
The presentations include new data from clinical trials and real-world evidence which reinforce the clinically meaningful benefits of Sephience on lowering phenylalanine (Phe), significant diet liberalization and sustained metabolic control for the full spectrum of individuals living with phenylketo...
08-24 20:07
美股大行评级 | 富国上调闪迪目标价从1400美元升至1550美元；塔吉特、Workday、应用材料等获多家大行上调目标价
今日重点评级关注：富瑞：维持ProMIS Neurosciences"买入"评级，目标价从69美元升至100美元；Benchmark：维持Cineverse"买入"评级，目标价从12美元升至14美元
08-17 13:37
美股大行评级 | 潜在涨幅544.53%！Scynexis获古根海姆升目标价至33美元，维持"买入"评级
今日重点评级关注：古根海姆：维持Scynexis"买入"评级，目标价从24美元升至33美元；韦德布什：维持Kura Oncology"跑赢大市"评级，目标价从36美元升至38美元
08-14 11:51
